Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency

Clinical Immunology

Volumn 164, Issue , 2016, Pages 52-56

  Klemann, Christian ^a   Pannicke, Ulrich ^b,c   Morris Rosendahl, Deborah J ^d   Vlantis, Katerina ^e   Rizzi, Marta ^a   Uhlig, Holm ^f   Vraetz, Thomas ^a   Speckmann, Carsten ^a   Strahm, Brigitte ^a   Pasparakis, Manolis ^e   Schwarz, Klaus ^a,b,c   Ehl, Stephan ^a   Rohr, Jan C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c German Red Cross Blood Transfusion Service Baden Württemberg Hessen and University Hospital Ulm   (Germany)

^d ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anti TNF treatment; Beh et's disease; HSCT; IBD; IKBKG; NEMO deficiency; Skewed X inactivation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; HLA B51 ANTIGEN; THYMOCYTE ANTIBODY; I KAPPA B KINASE; IKBKG PROTEIN, HUMAN;

ARTICLE; BACTERIAL MENINGITIS; BEHCET DISEASE; CASE REPORT; CELLULITIS; COLITIS; CROHN DISEASE; ENTEROBACTER CLOACAE; ERYTHEMA NODOSUM; FAMILY HISTORY; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS; HETEROZYGOTE; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN ESSENTIAL MODULATOR DEFICIENCY; INCONTINENTIA PIGMENTI; INTERSTITIAL PNEUMONIA; INTESTINE EPITHELIUM CELL; LIVING DONOR; MOUTH ULCER; MYELOABLATIVE CONDITIONING; NECROTIZING FASCIITIS; POLYARTHRITIS; PRIORITY JOURNAL; STAPHYLOCOCCAL SCROTAL CELLULITIS; STOP CODON; UVEITIS; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKED DISORDER; ALLELE; BEHCET SYNDROME; DEFICIENCY; GENETICS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; MALE; SIBLING;

ALLELES; BEHCET SYNDROME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; I-KAPPA B KINASE; INFLAMMATORY BOWEL DISEASES; MALE; SIBLINGS;

EID: 84957599371     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2016.01.010     Document Type: Article

References (29)

1. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18:621-663. 10.1146/annurev.immunol.18.1.621.
2. Picard C., Casanova J.-L., Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin. Microbiol. Rev. 2011, 24:490-497. 10.1128/CMR.00001-11.
3. Zonana J., Elder M.E., Schneider L.C., Orlow S.J., Moss C., Golabi M., et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am. J. Hum. Genet. 2000, 67:1555-1562. 10.1086/316914.
4. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-κB signaling pathways. Nat. Immunol. 2011, 12:695-708. 10.1038/ni.2065.
5. O'Donnell M.A., Hase H., Legarda D., Ting A.T. NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1. PLoS ONE 2012, 7. 10.1371/journal.pone.0041238.
6. Margalef P., Fernández-Majada V., Villanueva A., Garcia-Carbonell R., Iglesias M., López L., et al. A truncated form of IKKα is responsible for specific nuclear IKK activity in colorectal cancer. Cell Rep. 2012, 2:840-854. 10.1016/j.celrep.2012.08.028.
7. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561. 10.1038/nature05698.
8. Nenci A., Huth M., Funteh A., Schmidt-Supprian M., Bloch W., Metzger D., et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum. Mol. Genet. 2006, 15:531-542. 10.1093/hmg/ddi470.
9. Hanson E.P., Monaco-Shawver L., Solt L.A., Madge L.A., Banerjee P.P., May M.J., et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J. Allergy Clin. Immunol. 2008, 122:1169-1177.e16. 10.1016/j.jaci.2008.08.018.
10. A.R. Huppmann, J.W. Leiding, A.P. Hsu, M. Raffeld, G. Uzel, S. Pittaluga et al., Pathologic findings in NEMO deficiency: a surgical and autopsy survey, Pediatr. Dev. Pathol. 18 387-400. doi:10.2350/15-05-1631-OA.1.
11. Tono C., Takahashi Y., Terui K., Sasaki S., Kamio T., Tandai S., et al. Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen. Bone Marrow Transplant. 2007, 39:801-804. 10.1038/sj.bmt.1705658.
12. Dupuis-Girod S., Cancrini C., Le Deist F., Palma P., Bodemer C., Puel A., et al. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics 2006, 118:e205-e211. 10.1542/peds.2005-2661.
13. Fish J.D., Duerst R.E., Gelfand E.W., Orange J.S., Bunin N. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency. Bone Marrow Transplant. 2009, 43:217-221. 10.1038/bmt.2008.308.
14. Pai S.-Y., Levy O., Jabara H.H., Glickman J.N., Stoler-Barak L., Sachs J., et al. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency. J. Allergy Clin. Immunol. 2008, 122:1113-1118.e1. 10.1016/j.jaci.2008.08.026.
15. Mizukami T., Obara M., Nishikomori R., Kawai T., Tahara Y., Sameshima N., et al. Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J. Clin. Immunol. 2012, 32:39-49. 10.1007/s10875-011-9600-0.
16. Martinez-Pomar N., Munoz-Saa I., Heine-Suner D., Martin A., Smahi A., Matamoros N. A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency. Hum. Genet. 2005, 118:458-465. 10.1007/s00439-005-0068-y.
17. Allen R.C., Zoghbi H.Y., Moseley A.B., Rosenblatt H.M., Belmont J.W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am. J. Hum. Genet. 1992, 51:1229-1239.
18. Bryceson Y.T., Pende D., Maul-Pavicic A., Gilmour K.C., Ufheil H., Vraetz T., et al. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood 2012, 119:2754-2763. 10.1182/blood-2011-08-374199.
19. Dannappel M., Vlantis K., Kumari S., Polykratis A., Kim C., Wachsmuth L., et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 2014, 513:90-94. 10.1038/nature13608.
20. Orange J.S., Brodeur S.R., Jain A., Bonilla F.A., Schneider L.C., Kretschmer R., et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J. Clin. Invest. 2002, 109:1501-1509. 10.1172/JCI14858.
21. Takada H., Nomura A., Ishimura M., Ichiyama M., Ohga S., Hara T. NEMO mutation as a cause of familial occurrence of Behçet's disease in female patients. Clin. Genet. 2010, 78:575-579. 10.1111/j.1399-0004.2010.01432.x.
22. Abbott J.K., Quinones R.R., de la Morena M.T., Gelfand E.W. Successful hematopoietic cell transplantation in patients with unique NF-kappaB essential modulator (NEMO) mutations. Bone Marrow Transplant. 2014, 49:1446-1447. 10.1038/bmt.2014.157.
23. Dupuis-Girod S., Corradini N., Hadj-Rabia S., Fournet J.-C., Faivre L., Le Deist F., et al. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 2002, 109.
24. Imamura M., Kawai T., Okada S., Izawa K., Takachi T., Iwabuchi H., et al. Disseminated BCG infection mimicking metastatic nasopharyngeal carcinoma in an immunodeficient child with a novel hypomorphic NEMO mutation. J. Clin. Immunol. 2011, 31:802-810. 10.1007/s10875-011-9568-9.
25. Kawai T., Nishikomori R., Izawa K., Murata Y., Tanaka N., Sakai H., et al. Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. Blood 2012, 119:5458-5466. 10.1182/blood-2011-05-354167.
26. Mancini A.J., Lawley L.P., Uzel G. X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis. Arch. Dermatol. 2008, 144:342-346. 10.1001/archderm.144.3.342.
27. Permaul P., Narla A., Hornick J.L., Pai S.-Y. Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes. Immunol. Res. 2009, 44:89-98. 10.1007/s12026-008-8085-2.
28. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 2009, 9:778-788. 10.1038/nri2655.
29. Cheng L.E., Kanwar B., Tcheurekdjian H., Grenert J.P., Muskat M., Heyman M.B., et al. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin. Immunol. 2009, 132:124-131. 10.1016/j.clim.2009.03.514.